Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (426)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
94
2023
2066
9.490
 Why?
Adrenal Cortex Hormones
26
2023
509
3.230
 Why?
Anti-Asthmatic Agents
26
2022
350
3.070
 Why?
Forced Expiratory Volume
19
2019
516
1.680
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
1098
1.450
 Why?
Severity of Illness Index
20
2020
2578
1.100
 Why?
Anti-Inflammatory Agents
10
2016
448
0.970
 Why?
Lung Transplantation
10
2017
246
0.970
 Why?
Administration, Inhalation
23
2022
644
0.930
 Why?
Albuterol
5
2015
105
0.910
 Why?
Bronchodilator Agents
12
2016
249
0.870
 Why?
Budesonide
14
2016
87
0.860
 Why?
Self Report
3
2023
698
0.790
 Why?
Humans
123
2023
115589
0.780
 Why?
Nedocromil
11
2016
32
0.780
 Why?
Nasal Polyps
1
2021
49
0.760
 Why?
Endpoint Determination
2
2020
69
0.740
 Why?
Pharmacogenetics
2
2015
151
0.740
 Why?
Sinusitis
1
2021
175
0.670
 Why?
Hospitalization
13
2020
1765
0.660
 Why?
Lung
7
2019
3672
0.660
 Why?
Physicians
2
2021
776
0.650
 Why?
Virus Diseases
1
2021
200
0.650
 Why?
Sleep Apnea, Obstructive
1
2021
194
0.630
 Why?
Glucocorticoids
4
2022
552
0.620
 Why?
Food Hypersensitivity
1
2022
254
0.610
 Why?
Symptom Assessment
1
2019
121
0.610
 Why?
Child
53
2022
18489
0.590
 Why?
Disease Progression
14
2020
2418
0.570
 Why?
Oxygen Inhalation Therapy
4
2020
130
0.570
 Why?
Emergency Service, Hospital
9
2013
1829
0.560
 Why?
Male
79
2020
55949
0.560
 Why?
Bone Density
2
2014
432
0.560
 Why?
Androstadienes
3
2012
97
0.550
 Why?
Patient Reported Outcome Measures
1
2018
250
0.550
 Why?
Adult
44
2023
30719
0.550
 Why?
Precision Medicine
1
2020
344
0.540
 Why?
Managed Care Programs
8
2008
135
0.530
 Why?
Female
78
2020
59913
0.530
 Why?
Practice Patterns, Physicians'
7
2020
1180
0.500
 Why?
Cost Savings
1
2015
75
0.490
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
34
0.480
 Why?
Middle Aged
37
2020
26998
0.460
 Why?
Cost-Benefit Analysis
7
2022
548
0.440
 Why?
Peak Expiratory Flow Rate
2
2011
35
0.440
 Why?
Comorbidity
4
2021
1473
0.410
 Why?
Adolescent
36
2019
17890
0.390
 Why?
Surveys and Questionnaires
13
2022
4665
0.380
 Why?
Remote Consultation
2
2022
42
0.370
 Why?
Mentors
1
2012
162
0.370
 Why?
Child, Preschool
31
2016
9133
0.370
 Why?
Administration, Oral
6
2021
734
0.370
 Why?
United States
22
2022
12295
0.370
 Why?
Medical Records Systems, Computerized
3
2008
90
0.360
 Why?
Respiratory Function Tests
10
2015
535
0.360
 Why?
Faculty, Medical
1
2012
234
0.350
 Why?
Medication Adherence
3
2023
538
0.350
 Why?
Child Development
1
2014
389
0.350
 Why?
Aged
22
2022
19250
0.340
 Why?
Interprofessional Relations
3
2021
258
0.340
 Why?
Treatment Outcome
15
2017
9159
0.340
 Why?
Spirometry
8
2020
253
0.340
 Why?
Oxygen
3
2018
837
0.330
 Why?
Group Practice
1
2008
7
0.310
 Why?
Computer Simulation
1
2012
881
0.310
 Why?
Anti-Allergic Agents
2
2008
41
0.310
 Why?
Phenotype
5
2021
2829
0.300
 Why?
Quality of Life
11
2023
2385
0.300
 Why?
Dyspnea
3
2022
223
0.290
 Why?
Follow-Up Studies
17
2017
4440
0.280
 Why?
Drug Utilization
4
2005
167
0.270
 Why?
Primary Graft Dysfunction
2
2017
32
0.270
 Why?
Randomized Controlled Trials as Topic
7
2020
1216
0.260
 Why?
Quality Assurance, Health Care
1
2008
315
0.260
 Why?
Genetic Testing
1
2008
382
0.260
 Why?
Bronchiolitis Obliterans
3
2017
66
0.260
 Why?
Gift Giving
1
2005
9
0.250
 Why?
Respiratory Sounds
1
2006
111
0.250
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.250
 Why?
Allergists
2
2022
19
0.250
 Why?
Delivery of Health Care
2
2021
844
0.250
 Why?
Leadership
2
2022
302
0.240
 Why?
Cohort Studies
14
2013
4944
0.240
 Why?
Retrospective Studies
17
2022
12608
0.240
 Why?
Antibodies, Monoclonal
2
2008
1265
0.240
 Why?
Time Factors
10
2020
6165
0.240
 Why?
Massachusetts
5
2016
137
0.230
 Why?
Young Adult
11
2019
10470
0.230
 Why?
Recurrence
5
2013
952
0.220
 Why?
Genetic Variation
1
2008
878
0.220
 Why?
Health Status
1
2008
728
0.220
 Why?
Predictive Value of Tests
9
2012
1805
0.220
 Why?
Steroids
8
2011
147
0.210
 Why?
Rhinitis, Allergic, Perennial
1
2003
24
0.210
 Why?
Prevalence
4
2022
2264
0.210
 Why?
Multicenter Studies as Topic
4
2018
249
0.210
 Why?
Biomarkers
3
2021
3467
0.210
 Why?
Beclomethasone
1
2022
25
0.200
 Why?
Academic Medical Centers
2
2022
414
0.200
 Why?
Models, Theoretical
4
2007
519
0.200
 Why?
Social Class
2
2022
210
0.190
 Why?
Patient Preference
1
2023
171
0.190
 Why?
Tiotropium Bromide
2
2018
19
0.190
 Why?
Nebulizers and Vaporizers
2
2020
80
0.190
 Why?
Desensitization, Immunologic
1
2022
117
0.180
 Why?
Risk Factors
12
2018
8697
0.180
 Why?
Churg-Strauss Syndrome
1
2020
17
0.180
 Why?
Bronchoconstriction
3
2011
27
0.180
 Why?
Capacity Building
1
2021
51
0.180
 Why?
Physician-Patient Relations
2
2021
465
0.180
 Why?
Pulmonologists
1
2020
16
0.180
 Why?
Granulomatosis with Polyangiitis
1
2020
41
0.180
 Why?
Air Pollution, Indoor
2
2002
109
0.180
 Why?
Agammaglobulinemia
1
2020
29
0.180
 Why?
Muscarinic Antagonists
1
2020
27
0.180
 Why?
Practice Guidelines as Topic
5
2020
1405
0.170
 Why?
Specialization
1
2021
117
0.170
 Why?
Exercise Test
1
2022
539
0.160
 Why?
Treatment Adherence and Compliance
1
2019
18
0.160
 Why?
Prognosis
8
2017
3339
0.160
 Why?
Receptors, IgE
2
2009
40
0.160
 Why?
Primary Health Care
4
2021
1518
0.160
 Why?
Vitamin D
2
2012
341
0.150
 Why?
Fossil Fuels
1
1997
8
0.150
 Why?
Biological Products
1
2020
172
0.150
 Why?
Allergens
1
2021
418
0.150
 Why?
Alemtuzumab
1
2017
12
0.150
 Why?
Drug Prescriptions
2
2011
241
0.150
 Why?
Aged, 80 and over
6
2019
6417
0.140
 Why?
Photopheresis
1
2017
9
0.140
 Why?
Hypersensitivity
1
2020
260
0.140
 Why?
Respiration
1
2017
177
0.140
 Why?
Emergency Medical Services
2
2007
590
0.140
 Why?
Respiration Disorders
1
1997
68
0.140
 Why?
Drug Combinations
3
2012
289
0.140
 Why?
Physicians, Primary Care
3
2021
222
0.140
 Why?
Immunomodulation
1
2017
85
0.140
 Why?
Drug Therapy, Combination
5
2020
962
0.130
 Why?
Statistics, Nonparametric
1
2017
390
0.130
 Why?
Patient Admission
1
2018
175
0.130
 Why?
Immunoglobulin G
1
2020
781
0.130
 Why?
Referral and Consultation
1
2021
646
0.130
 Why?
Postoperative Complications
2
2017
2161
0.130
 Why?
Breath Tests
2
2008
83
0.130
 Why?
Scopolamine Derivatives
1
2015
6
0.130
 Why?
Embolism, Fat
1
2015
10
0.130
 Why?
Longitudinal Studies
6
2017
2416
0.130
 Why?
Tobacco Smoke Pollution
2
2010
221
0.130
 Why?
Genomics
2
2018
646
0.130
 Why?
Cholinergic Antagonists
1
2015
27
0.130
 Why?
Transplants
1
2015
37
0.130
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
95
0.130
 Why?
Overweight
2
2011
469
0.130
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
12
0.130
 Why?
Carcinoma, Bronchogenic
1
2015
17
0.120
 Why?
Telemedicine
1
2023
667
0.120
 Why?
Respiratory Tract Infections
2
2012
323
0.120
 Why?
Graft Rejection
2
2013
533
0.120
 Why?
Environmental Exposure
3
2006
378
0.120
 Why?
Quality Improvement
1
2022
958
0.120
 Why?
Ambulatory Care Information Systems
2
2005
5
0.120
 Why?
Guideline Adherence
3
2020
497
0.120
 Why?
Prednisolone
1
2014
77
0.110
 Why?
Risk
4
2015
819
0.110
 Why?
Education, Medical, Continuing
2
2005
119
0.110
 Why?
Antibodies, Monoclonal, Humanized
2
2008
667
0.110
 Why?
Forecasting
1
2015
333
0.110
 Why?
Peer Group
2
2012
206
0.110
 Why?
Bronchial Hyperreactivity
3
2010
96
0.110
 Why?
Medicare
2
2022
666
0.110
 Why?
Transplantation
1
2013
23
0.110
 Why?
Airway Obstruction
1
2015
168
0.110
 Why?
Double-Blind Method
5
2010
1659
0.110
 Why?
Office Visits
4
2011
79
0.110
 Why?
Insurance Claim Review
1
2013
67
0.110
 Why?
Research
1
2015
396
0.100
 Why?
Growth
1
2012
56
0.100
 Why?
Costs and Cost Analysis
1
2013
200
0.100
 Why?
Methacholine Chloride
3
2008
47
0.100
 Why?
Metered Dose Inhalers
1
2012
14
0.100
 Why?
Feedback
1
2012
148
0.100
 Why?
Logistic Models
5
2017
1856
0.100
 Why?
Mycoses
1
2012
67
0.100
 Why?
Cytomegalovirus Infections
2
2012
182
0.100
 Why?
Drug Dosage Calculations
1
2011
21
0.100
 Why?
Socioeconomic Factors
3
2022
1086
0.100
 Why?
Obesity
3
2015
2517
0.100
 Why?
Antifungal Agents
1
2012
133
0.100
 Why?
Body Height
1
2012
180
0.100
 Why?
Effect Modifier, Epidemiologic
1
2011
12
0.100
 Why?
Multivariate Analysis
7
2017
1440
0.100
 Why?
Morbidity
2
2022
278
0.100
 Why?
Professional Role
1
2012
153
0.100
 Why?
Medication Errors
1
2012
89
0.090
 Why?
Patient Readmission
1
2016
609
0.090
 Why?
Epidemiologic Studies
1
2011
58
0.090
 Why?
Diagnostic Errors
1
2012
151
0.090
 Why?
Mycobacterium
1
2012
103
0.090
 Why?
Pneumococcal Vaccines
1
2012
132
0.090
 Why?
Secondary Prevention
1
2012
223
0.090
 Why?
Decision Support Techniques
2
2012
353
0.090
 Why?
Program Development
1
2012
350
0.090
 Why?
Ambulatory Care
2
2011
478
0.090
 Why?
Lung Diseases
1
2017
710
0.090
 Why?
Drug Resistance
1
2011
162
0.090
 Why?
Vitamin D Deficiency
1
2012
159
0.090
 Why?
Incidence
5
2020
2335
0.090
 Why?
Probability
1
2011
294
0.090
 Why?
Chi-Square Distribution
2
2017
499
0.090
 Why?
Bronchial Provocation Tests
2
2008
53
0.090
 Why?
Cross-Sectional Studies
6
2010
4435
0.090
 Why?
Algorithms
1
2017
1490
0.090
 Why?
Fluticasone
2
2008
87
0.090
 Why?
Immunoglobulin E
2
2008
328
0.090
 Why?
Vital Capacity
4
2017
277
0.090
 Why?
Lectins, C-Type
1
2009
61
0.080
 Why?
Proportional Hazards Models
1
2012
1087
0.080
 Why?
Surgical Wound Infection
1
2012
250
0.080
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
33
0.080
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1198
0.080
 Why?
Pandemics
3
2022
1334
0.080
 Why?
Health Services
2
2007
104
0.080
 Why?
Acute Disease
1
2011
914
0.080
 Why?
Odds Ratio
4
2017
962
0.080
 Why?
Smoking
3
2017
1457
0.080
 Why?
Kaplan-Meier Estimate
3
2016
815
0.080
 Why?
Medication Therapy Management
1
2010
67
0.080
 Why?
Vitamin K Epoxide Reductases
1
2008
12
0.080
 Why?
Cytochrome P-450 CYP2C9
1
2008
18
0.080
 Why?
Health Services Accessibility
2
2021
771
0.080
 Why?
Eosinophil Cationic Protein
1
2008
9
0.080
 Why?
Interviews as Topic
1
2011
596
0.080
 Why?
Genetic Predisposition to Disease
1
2016
2125
0.080
 Why?
Program Evaluation
1
2012
836
0.080
 Why?
Mixed Function Oxygenases
1
2008
37
0.080
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
41
0.080
 Why?
Genetic Techniques
1
2008
57
0.080
 Why?
Trastuzumab
1
2008
89
0.080
 Why?
Cost Sharing
1
2008
14
0.080
 Why?
Quality-Adjusted Life Years
2
2006
103
0.080
 Why?
Markov Chains
2
2006
114
0.080
 Why?
Exercise Tolerance
2
2022
223
0.080
 Why?
Insurance, Pharmaceutical Services
1
2008
23
0.080
 Why?
Smoking Cessation
1
2012
377
0.080
 Why?
State Health Plans
1
2008
32
0.080
 Why?
Adrenergic beta-Agonists
1
2008
129
0.070
 Why?
Databases, Factual
1
2012
1138
0.070
 Why?
Chronic Disease
3
2017
1598
0.070
 Why?
Reimbursement Mechanisms
1
2008
78
0.070
 Why?
Lung Diseases, Interstitial
1
2013
520
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
54
0.070
 Why?
Tomography, X-Ray Computed
1
2017
2392
0.070
 Why?
Warfarin
1
2008
136
0.070
 Why?
Omalizumab
1
2007
46
0.070
 Why?
Factor Analysis, Statistical
1
2008
261
0.070
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
337
0.070
 Why?
Health Surveys
2
2006
446
0.070
 Why?
Antiviral Agents
1
2012
651
0.070
 Why?
Influenza Vaccines
1
2012
498
0.070
 Why?
Animals, Domestic
1
2006
11
0.070
 Why?
Receptor, ErbB-2
1
2008
302
0.070
 Why?
Biomedical Research
1
2012
588
0.070
 Why?
Eosinophils
1
2008
282
0.070
 Why?
Infant
3
2008
7979
0.060
 Why?
Physicians, Family
2
2004
201
0.060
 Why?
Body Mass Index
3
2015
1971
0.060
 Why?
Models, Biological
1
2012
1646
0.060
 Why?
Health Benefit Plans, Employee
1
2005
20
0.060
 Why?
Health Policy
1
2008
334
0.060
 Why?
Clinical Competence
1
2012
912
0.060
 Why?
Database Management Systems
1
2005
50
0.060
 Why?
Mass Screening
1
2012
1024
0.060
 Why?
Hip Fractures
1
2006
75
0.060
 Why?
Patients
1
2006
164
0.060
 Why?
Prenatal Exposure Delayed Effects
1
2010
448
0.060
 Why?
Insurance Coverage
1
2006
204
0.060
 Why?
Patient Education as Topic
3
2005
686
0.060
 Why?
Gene Expression Profiling
1
2011
1536
0.060
 Why?
Utilization Review
1
2004
34
0.060
 Why?
Cost of Illness
2
2003
257
0.060
 Why?
Anticoagulants
1
2008
549
0.060
 Why?
Sex Factors
3
2016
1736
0.060
 Why?
Vaccination
1
2012
1209
0.060
 Why?
Anti-Bacterial Agents
2
2004
1483
0.060
 Why?
Medicaid
1
2008
411
0.060
 Why?
Parents
3
2006
1205
0.050
 Why?
Circadian Rhythm
1
2006
371
0.050
 Why?
Clinical Trials as Topic
2
2005
941
0.050
 Why?
Nitric Oxide
1
2008
832
0.050
 Why?
Attitude to Health
1
2006
409
0.050
 Why?
Case Management
1
2003
62
0.050
 Why?
Choice Behavior
1
2004
159
0.050
 Why?
Puerto Rico
1
2022
52
0.050
 Why?
Symptom Flare Up
1
2022
40
0.050
 Why?
Lung Neoplasms
1
2015
2207
0.050
 Why?
Sputum
1
2004
290
0.050
 Why?
Academies and Institutes
1
2022
44
0.050
 Why?
Minority Groups
1
2003
230
0.050
 Why?
Survival Rate
2
2016
1650
0.050
 Why?
Health Services Research
1
2004
377
0.050
 Why?
Clinical Trials, Phase II as Topic
1
2020
58
0.050
 Why?
Clinical Trials, Phase III as Topic
1
2020
84
0.050
 Why?
Electronics
1
2021
68
0.050
 Why?
Sample Size
1
2020
115
0.040
 Why?
Efficiency
1
2021
84
0.040
 Why?
Risk Assessment
3
2020
2987
0.040
 Why?
Language
1
2022
258
0.040
 Why?
Health Care Reform
1
2021
92
0.040
 Why?
Schools, Medical
1
2021
123
0.040
 Why?
Pragmatic Clinical Trials as Topic
1
2020
48
0.040
 Why?
Patient Selection
2
2020
654
0.040
 Why?
Patient Compliance
2
2016
524
0.040
 Why?
Stress, Psychological
1
2007
974
0.040
 Why?
Time
1
2019
72
0.040
 Why?
Health Education
1
2002
325
0.040
 Why?
Cluster Analysis
2
2014
465
0.040
 Why?
Quality of Health Care
1
2003
576
0.040
 Why?
Cooperative Behavior
1
2021
390
0.040
 Why?
Republic of Korea
1
2017
27
0.040
 Why?
Poland
1
2017
28
0.040
 Why?
Sensitivity and Specificity
3
2013
1718
0.040
 Why?
Bronchitis, Chronic
1
2017
20
0.040
 Why?
Patient-Centered Care
1
2003
477
0.040
 Why?
Nitrogen Dioxide
1
1997
20
0.040
 Why?
Antineoplastic Agents
1
2008
1893
0.040
 Why?
Long-Term Care
1
2018
76
0.040
 Why?
Pediatrics
1
2005
986
0.040
 Why?
Geography
1
2018
181
0.040
 Why?
Self Concept
1
2019
218
0.040
 Why?
Aftercare
1
2019
187
0.040
 Why?
Monitoring, Physiologic
2
2012
250
0.040
 Why?
Netherlands
1
2016
64
0.040
 Why?
Feasibility Studies
1
2020
741
0.040
 Why?
Tuberculosis, Pulmonary
1
2017
112
0.030
 Why?
Perception
1
2019
315
0.030
 Why?
Formoterol Fumarate
1
2015
8
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
12
0.030
 Why?
Salmeterol Xinafoate
1
2015
41
0.030
 Why?
Ethanolamines
1
2015
20
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
42
0.030
 Why?
Immunosuppressive Agents
2
2015
666
0.030
 Why?
Treatment Failure
1
2016
332
0.030
 Why?
Self Efficacy
1
2019
361
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
1870
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
1918
0.030
 Why?
Postoperative Period
1
2016
292
0.030
 Why?
Age Factors
3
2008
2907
0.030
 Why?
Education
1
2015
99
0.030
 Why?
Pilot Projects
1
2020
1377
0.030
 Why?
Patient Acceptance of Health Care
1
2021
682
0.030
 Why?
Fatal Outcome
1
2015
286
0.030
 Why?
Biopsy
2
2013
1056
0.030
 Why?
Combined Modality Therapy
1
2017
1127
0.030
 Why?
Gene Expression
1
2018
1436
0.030
 Why?
Tissue Donors
1
2015
331
0.030
 Why?
Telephone
2
2005
153
0.030
 Why?
Hypoxia
1
2019
937
0.030
 Why?
Lipopeptides
1
2012
14
0.030
 Why?
Extracorporeal Membrane Oxygenation
1
2015
243
0.030
 Why?
Echinocandins
1
2012
8
0.030
 Why?
Intention to Treat Analysis
1
2012
69
0.030
 Why?
Amphotericin B
1
2012
32
0.030
 Why?
Aspergillosis
1
2012
24
0.030
 Why?
Candidiasis
1
2012
58
0.030
 Why?
Transplantation, Homologous
1
2013
397
0.020
 Why?
Age Distribution
2
2003
341
0.020
 Why?
Mycobacterium avium Complex
1
2012
92
0.020
 Why?
Triazoles
1
2012
132
0.020
 Why?
Cromolyn Sodium
2
2001
13
0.020
 Why?
Colorado
1
2021
4113
0.020
 Why?
Self Care
2
2005
354
0.020
 Why?
Leukotriene Antagonists
1
2011
41
0.020
 Why?
Reference Values
1
2012
744
0.020
 Why?
Functional Residual Capacity
1
2010
6
0.020
 Why?
Costa Rica
1
2010
16
0.020
 Why?
Principal Component Analysis
1
2011
177
0.020
 Why?
Genome-Wide Association Study
1
2016
1217
0.020
 Why?
Health
1
2010
74
0.020
 Why?
Inhalation
1
2010
24
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
207
0.020
 Why?
Prospective Studies
2
2012
6264
0.020
 Why?
Environment
1
2011
337
0.020
 Why?
Observation
1
2008
50
0.020
 Why?
Sex Ratio
1
2008
14
0.020
 Why?
Least-Squares Analysis
1
2008
73
0.020
 Why?
Models, Econometric
1
2008
34
0.020
 Why?
Health Services Administration
1
2007
7
0.020
 Why?
Social Isolation
1
2007
54
0.020
 Why?
Treatment Refusal
1
2008
85
0.020
 Why?
Puberty
1
2008
137
0.020
 Why?
Intelligence
1
2007
132
0.020
 Why?
Body Weight
1
2011
867
0.020
 Why?
Exercise
1
2016
1609
0.020
 Why?
Child Behavior Disorders
1
2007
128
0.020
 Why?
Animals
1
2006
32102
0.020
 Why?
Insurance, Health
1
2007
246
0.020
 Why?
CD4-Positive T-Lymphocytes
1
2011
965
0.020
 Why?
Genotype
1
2009
1787
0.010
 Why?
Bronchoconstrictor Agents
1
2003
14
0.010
 Why?
Case-Control Studies
1
2010
3022
0.010
 Why?
Health Status Indicators
1
2004
155
0.010
 Why?
Organizational Innovation
1
2004
132
0.010
 Why?
Systems Integration
1
2003
38
0.010
 Why?
Computer Systems
1
2003
46
0.010
 Why?
Motor Activity
1
2007
633
0.010
 Why?
Child Welfare
1
2004
197
0.010
 Why?
Self Disclosure
1
2002
59
0.010
 Why?
Histamine H1 Antagonists
1
2002
33
0.010
 Why?
Drug Administration Schedule
1
2004
724
0.010
 Why?
Administration, Intranasal
1
2002
75
0.010
 Why?
Nurse's Role
1
2003
106
0.010
 Why?
Point-of-Care Systems
1
2003
141
0.010
 Why?
Confidence Intervals
1
2002
309
0.010
 Why?
Regression Analysis
1
2003
959
0.010
 Why?
Caregivers
1
2007
713
0.010
 Why?
Health Care Surveys
1
2002
538
0.010
 Why?
Sex Distribution
1
2001
337
0.010
 Why?
Decision Support Systems, Clinical
1
2003
179
0.010
 Why?
Patient Satisfaction
1
2004
585
0.010
 Why?
Disease Management
1
2003
563
0.010
 Why?
Linear Models
1
2002
776
0.010
 Why?
Pregnancy
1
2010
5549
0.010
 Why?
Internet
1
2003
602
0.010
 Why?
Bronchoscopy
1
2000
245
0.010
 Why?
Survival Analysis
1
2000
1219
0.010
 Why?
Infant, Newborn
1
2004
5077
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (426) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)